Biomarkers in Prediction of AMI

Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Inclusion Criteria:

• Age 18 years or older
• Initial decision in favour of further diagnostics of mesenteric ischaemia

Exclusion Criteria:

• Age <18 years
• Consent declined by patient or next of kin (delayed consent)
• Chronic mesenteric ischaemia without an acute event
• Immediate decision for withdrawal of further diagnostics and active treatment
• Referral from another hospital with already established diagnosis of AMI
• AMI diagnosed at surgery without previously having been considered